GSK 343
Chemical Name: N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide
Purity: ≥98%
Biological Activity
GSK 343 is a potent and selective SAM-competitive EZH2 inhibitor (IC50 = 4 nM), that exhibits >60 fold selectivity for EZH2 over EZH1 and a range of other methyltransferases. GSK 343 decreases H3K27me3 levels in breast cancer cells and inhibits proliferation of prostate cancer cell lines in vitro.External Portal Information
Chemicalprobes.org is a portal that offers independent guidance on the selection and/or application of small molecules for research. The use of GSK 343 is reviewed on the chemical probes website.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling.
Scheer et al.
Nat.Commun., 2019;10:19 -
Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2.
Verma et al.
ACS Med.Chem.Lett., 2012;3:1091
Product Datasheets
Citation for GSK 343
The citations listed below are publications that use Tocris products. Selected citations for GSK 343 include:
1 Citation: Showing 1 - 1
-
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma.
Authors: Karin Et al.
Cell Death Dis 2021;12:167
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for GSK 343
There are currently no reviews for this product. Be the first to review GSK 343 and earn rewards!
Have you used GSK 343?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image